Imperial Valley News Center
Washington, DC - After a public comment period, the Federal Trade Commission has approved a final order resolving the Commission’s complaint against ASUSTeK Computer, Inc., charging that critical security flaws in its routers put the home networks of hundreds of thousands of consumers at risk.
Washington, DC - The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
Washington, DC - The U.S. Department of Energy (DOE) has announced the selection of eight new research and development projects to receive a total of $11.5 million in federal funding under DOE’s Subsurface Technology and Engineering Research, Development, and Demonstration Crosscut initiative. The new projects are focused on furthering geothermal energy and carbon storage technologies, and will be funded by the Office of Energy Efficiency and Renewable Energy’s Geothermal Technologies Office (GTO) and the Office of Fossil Energy’s (FE) Carbon Storage program.
Washington, DC - The 4th United States-Japan Bilateral Cyber Dialogue was held in Washington D.C. on July 27, 2016.
West Lafayette, Indiana - Among the Central African Republic forager communities, it is older women who suffer the most from the region's ongoing food shortage, according to an anthropologist from Purdue University.
FTC Requires Teva to Divest Over 75 Generic Drugs to Settle Competition Concerns Related to its Acquisition of Allergan’s Generic Business
Washington, DC - Teva Pharmaceutical Industries Ltd. has agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan plc’s generic pharmaceutical business would be anticompetitive. The remedy requires Teva to divest the drug portfolio to eleven firms, and marks the largest drug divestiture order in an FTC pharmaceutical merger case.
Page 487 of 2173